Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
2.140
-0.060 (-2.73%)
Mar 31, 2025, 9:30 AM EST - Market open
Perspective Therapeutics Stock Forecast
CATX's stock price has decreased by -81.67% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Perspective Therapeutics stock have an average target of 15.3, with a low estimate of 6.00 and a high estimate of 22. The average target predicts an increase of 614.95% from the current stock price of 2.14.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Perspective Therapeutics stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 4 | 4 | 4 | 5 |
| Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +367.29% | Mar 31, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $16 → $15 | Buy | Maintains | $16 → $15 | +600.93% | Mar 27, 2025 |
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +414.02% | Mar 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +367.29% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +367.29% | Mar 13, 2025 |
Financial Forecast
Revenue This Year
751.13K
from 1.45M
Decreased by -48.34%
Revenue Next Year
759.78K
from 751.13K
Increased by 1.15%
EPS This Year
-1.26
from -1.23
EPS Next Year
-1.56
from -1.26
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.5M | 2.5M | 88.5M | ||
| Avg | 751,128 | 759,778 | 14.7M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 71.9% | 235.5% | 11,550.1% | ||
| Avg | -48.3% | 1.2% | 1,832.0% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.04 | -1.07 | -2.02 | ||
| Avg | -1.26 | -1.56 | -1.96 | ||
| Low | -1.81 | -2.02 | -1.88 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.